JPMORGAN CHASE & CO - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 165 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,634,967
-66.2%
481,305
-62.7%
0.00%0.0%
Q2 2023$13,730,079
+105.5%
1,290,421
+103.2%
0.00%0.0%
Q1 2023$6,681,000
+27016.6%
635,108
-68.1%
0.00%
-66.7%
Q4 2022$24,638
-99.6%
1,988,627
+242.2%
0.00%
+200.0%
Q3 2022$6,022,000
-27.2%
581,168
-19.0%
0.00%0.0%
Q2 2022$8,273,000
-17.1%
717,404
-9.5%
0.00%0.0%
Q1 2022$9,974,000
-33.0%
792,800
-37.9%
0.00%
-50.0%
Q4 2021$14,889,000
-35.5%
1,276,908
-27.7%
0.00%
-33.3%
Q3 2021$23,068,000
+94.3%
1,766,294
+91.5%
0.00%
+200.0%
Q2 2021$11,872,000
-8.4%
922,467
-20.5%
0.00%
-50.0%
Q1 2021$12,966,000
+125.5%
1,159,775
+129.8%
0.00%
+100.0%
Q4 2020$5,749,000
+638.9%
504,681
+510.8%
0.00%
Q3 2020$778,000
-6.5%
82,629
+2.4%
0.00%
Q2 2020$832,000
-29.8%
80,654
-31.3%
0.00%
Q1 2020$1,185,000
-32.6%
117,400
-11.1%
0.00%
Q4 2019$1,757,000
+17.8%
132,045
-23.9%
0.00%
Q3 2019$1,491,000
+148.5%
173,574
+212.1%
0.00%
Q2 2019$600,000
-89.3%
55,610
-86.6%
0.00%
-100.0%
Q1 2019$5,609,000
+109.6%
414,513
+60.5%
0.00%0.0%
Q4 2018$2,676,000
+32.5%
258,308
+136.0%
0.00%
Q3 2018$2,020,000
-81.6%
109,435
-81.0%
0.00%
-100.0%
Q2 2018$10,988,000
+627.2%
574,669
+486.4%
0.00%
Q1 2018$1,511,000
-77.4%
97,992
-78.1%
0.00%
-100.0%
Q4 2017$6,696,000
+2053.1%
446,701
+2177.9%
0.00%
Q3 2017$311,000
-76.9%
19,610
-72.5%
0.00%
Q2 2017$1,346,000
-72.2%
71,311
-74.9%
0.00%
-100.0%
Q1 2017$4,850,000
+3364.3%
284,369
+3004.1%
0.00%
Q4 2016$140,000
+418.5%
9,161
+448.9%
0.00%
Q3 2016$27,000
-99.6%
1,669
-99.7%
0.00%
-100.0%
Q2 2016$7,237,000
-13.5%
553,489
-27.6%
0.00%0.0%
Q1 2016$8,365,000
-4.3%
764,631
+1.3%
0.00%0.0%
Q4 2015$8,745,000
+15.1%
754,529
+3.4%
0.00%0.0%
Q3 2015$7,601,000
+20.9%
729,407
+39.9%
0.00%
+100.0%
Q2 2015$6,285,000
-67.0%
521,210
-56.3%
0.00%
-75.0%
Q1 2015$19,071,000
+1158.8%
1,191,963
+1105.2%
0.00%
Q4 2014$1,515,000
+227.2%
98,900
+176.5%
0.00%
Q3 2014$463,000
-85.9%
35,775
-86.5%
0.00%
-100.0%
Q1 2014$3,273,000
+116.6%
265,641
+104.2%
0.00%
Q4 2013$1,511,000
-12.9%
130,078
-11.2%
0.00%
-100.0%
Q3 2013$1,734,000
+81.0%
146,474
+51.7%
0.00%
Q2 2013$958,00096,5390.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders